NO20060908L - Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse - Google Patents

Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse

Info

Publication number
NO20060908L
NO20060908L NO20060908A NO20060908A NO20060908L NO 20060908 L NO20060908 L NO 20060908L NO 20060908 A NO20060908 A NO 20060908A NO 20060908 A NO20060908 A NO 20060908A NO 20060908 L NO20060908 L NO 20060908L
Authority
NO
Norway
Prior art keywords
tazole
substituted
preparation
dioxide derivatives
benzoisothiazole
Prior art date
Application number
NO20060908A
Other languages
English (en)
Norwegian (no)
Inventor
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Stefan Petry
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20060908L publication Critical patent/NO20060908L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20060908A 2003-07-28 2006-02-24 Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse NO20060908L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10334309A DE10334309A1 (de) 2003-07-28 2003-07-28 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2004/007847 WO2005012295A1 (de) 2003-07-28 2004-07-15 Substituierte thiazol-benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
NO20060908L true NO20060908L (no) 2006-02-24

Family

ID=34111694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060908A NO20060908L (no) 2003-07-28 2006-02-24 Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse

Country Status (38)

Country Link
EP (1) EP1651644B1 (da)
JP (1) JP2007500145A (da)
KR (1) KR20060052886A (da)
CN (1) CN100413862C (da)
AR (1) AR045113A1 (da)
AT (1) ATE346065T1 (da)
AU (1) AU2004261370B2 (da)
BR (1) BRPI0412997A (da)
CA (1) CA2533673A1 (da)
CR (1) CR8202A (da)
CY (1) CY1105962T1 (da)
DE (2) DE10334309A1 (da)
DK (1) DK1651644T3 (da)
EC (1) ECSP066326A (da)
ES (1) ES2276319T3 (da)
GT (1) GT200400146A (da)
HK (1) HK1091825A1 (da)
IL (1) IL173289A0 (da)
JO (1) JO2449B1 (da)
MA (1) MA27932A1 (da)
MY (1) MY141197A (da)
NO (1) NO20060908L (da)
NZ (1) NZ544975A (da)
OA (1) OA13198A (da)
PA (1) PA8607201A1 (da)
PE (1) PE20050326A1 (da)
PL (1) PL1651644T3 (da)
PT (1) PT1651644E (da)
RS (1) RS20060015A (da)
RU (1) RU2350613C2 (da)
SA (1) SA04250332B1 (da)
SI (1) SI1651644T1 (da)
TN (1) TNSN06030A1 (da)
TW (1) TW200524923A (da)
UA (1) UA83057C2 (da)
UY (1) UY28443A1 (da)
WO (1) WO2005012295A1 (da)
ZA (1) ZA200510378B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026532A1 (de) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
PT2402319T (pt) 2006-03-31 2017-12-11 Novartis Ag Inibidores de dgat
RU2009108280A (ru) 2006-08-08 2010-09-20 Санофи-Авентис (Fr) Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW201014822A (en) 2008-07-09 2010-04-16 Sanofi Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
JP2013503135A (ja) 2009-08-26 2013-01-31 サノフイ 新規な結晶性複素芳香族フルオログリコシド水和物、その化合物を含んでなる医薬及びその使用
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683700B1 (de) 2011-03-08 2015-02-18 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120051A1 (de) 2011-03-08 2012-09-13 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683701B1 (de) 2011-03-08 2014-12-24 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
EP1651644A1 (de) 2006-05-03
MA27932A1 (fr) 2006-06-01
MY141197A (en) 2010-03-31
RS20060015A (en) 2007-12-31
AU2004261370B2 (en) 2009-07-16
TNSN06030A1 (en) 2007-10-03
PT1651644E (pt) 2007-01-31
ATE346065T1 (de) 2006-12-15
NZ544975A (en) 2010-02-26
ECSP066326A (es) 2006-07-28
CN1829715A (zh) 2006-09-06
UY28443A1 (es) 2005-02-28
SI1651644T1 (sl) 2007-02-28
ZA200510378B (en) 2006-11-29
UA83057C2 (ru) 2008-06-10
AU2004261370A1 (en) 2005-02-10
BRPI0412997A (pt) 2006-10-03
DE502004002117D1 (de) 2007-01-04
AR045113A1 (es) 2005-10-19
DK1651644T3 (da) 2007-03-26
WO2005012295A1 (de) 2005-02-10
ES2276319T3 (es) 2007-06-16
KR20060052886A (ko) 2006-05-19
JP2007500145A (ja) 2007-01-11
JO2449B1 (en) 2008-10-09
CR8202A (es) 2008-10-15
GT200400146A (es) 2005-08-12
HK1091825A1 (en) 2007-01-26
CA2533673A1 (en) 2005-02-10
SA04250332B1 (ar) 2008-02-25
DE10334309A1 (de) 2005-03-03
PL1651644T3 (pl) 2007-03-30
CY1105962T1 (el) 2011-04-06
OA13198A (en) 2006-12-13
TW200524923A (en) 2005-08-01
PE20050326A1 (es) 2005-06-16
RU2350613C2 (ru) 2009-03-27
CN100413862C (zh) 2008-08-27
RU2006106231A (ru) 2006-06-27
EP1651644B1 (de) 2006-11-22
PA8607201A1 (es) 2005-03-03
IL173289A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
NO20060908L (no) Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
NO20050648L (no) Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20044882L (no) Acyl-4-karboksylfenylurinstoffderivater, deres fremstilling og anvendelse
NO20070176L (no) Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
NO20050828L (no) lndol-3-svovelderivater
NO20066055L (no) Pyridinderivater
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20081844L (no) Terapeutiske forbindelser
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
NO20074703L (no) Antibakterielle piperidinderivater
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20072389L (no) Substituerte benzokinolizinderivater
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
EP2397462A3 (en) Compounds, compositions and methods of treatment for heart failure
NO20074872L (no) Pyrazoler
NO20082496L (no) Pyrazinderivater
NO20062491L (no) Benzoksazinderivter og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application